Medical Science News

RSS

European Commission grants marketing authorization for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease

Neuraxpharm Group and Minoryx Therapeutics, today announce that the European Commission (EC) has granted marketing authorization under exceptional circumstances for NEZGLYAL® (leriglitazone), an orally bioavailable, brain penetrating, selective PPAR gamma agonist, as a treatment for male cALD patients, aged 2-12 years with Gadolinium (Gd)-negative brain lesions.

26 Sep 2026

MD Anderson researchers showcase new findings in radiation oncology at ASTRO 2026

Experts from The University of Texas MD Anderson Cancer Center will present nearly 70 abstracts at the 2026 American Society for Radiation Oncology (ASTRO) Annual Meeting.

25 Sep 2026

AI-generated video summaries can reshape people's memories of events

AI-generated summaries are becoming increasingly prevalent - from news article previews to workplace meeting transcriptions to high-stakes settings like police body camera footage - despite studies showing that AI can generate misleading or inaccurate information.

25 Sep 2026

Pupillary responses differ when judging glossiness and attractiveness

A research team from the Vision and Action Laboratory, Visual Perception and Cognition Laboratory, and Cognitive Neurotechnology Unit in the Department of Computer Science and Engineering at Toyohashi University of Technology, led by Associate Professor Hideki Tamura, has shown that the temporal patterns of pupillary responses differ depending on whether observers evaluate the same object images in terms of glossiness or attractiveness.

25 Sep 2026

Shared neural noise may not limit the brain's information capacity

Our brains internally represent the outside world through the coordinated activity of billions of neurons. A single neuron responds unreliably: even when the same stimulus is shown repeatedly, its activity varies from trial to trial.

25 Sep 2026

Existing drug helps bladder cells destroy hidden urinary tract infections

Urinary tract infections, or UTIs, are among the most common bacterial infections, caused mostly by the uropathogenic bacterium Escherichia coli. But even after antibiotic treatment, a large number of patients experience another UTI.

25 Sep 2026

Laser irradiation boosts antibody-antigen interactions to detect colorectal cancer

Researchers often use antibodies to detect specific molecules or biological markers, as they are remarkably precise at recognizing their targets.

25 Sep 2026

Better storage buffers could pave way for safer mRNA therapies

Researchers at The University of Texas at Austin have teamed up with pharmaceutical leader Eli Lilly and Company to uncover new information about mRNA lipid nanoparticles (LNPs), the technology behind COVID-19 vaccines and other important treatments, and how to make it more effective.

25 Sep 2026

New project aims to make cellular therapies more accessible through room temperature storage

The Advanced Research Projects Agency for Health, or ARPA-H, has executed an award of up to $36.5 million in support of a University of California, Davis-led project aiming to make cellular therapies cheaper and more accessible through room temperature storage.

25 Sep 2026

Researchers find how prostate tumors reshape the immune microenvironment

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown pathway that prostate tumors leverage to suppress the immune system by reshaping the tumor microenvironment to resist treatment.

25 Sep 2026

Specialized immune cells bridge the nervous and immune systems

A collaborative team led by Professor Jie Zhou at Tianjin Medical University School of Basic Medicine and Professor Qiang Liu at Tianjin Medical University General Hospital published a comprehensive review in Volume 2 of the journal Immunity & Inflammation on September 8, 2026.

25 Sep 2026

In vivo CAR-T therapy transforms customized treatments into universal medicines

A collaborative team led by Professor Huji Xu from Naval Medical University, China, together with Professors Xuanming Yang and Yujia Cai at Shanghai Jiao Tong University, China, published a comprehensive review in Volume 2, article number 33 of the journal Immunity & Inflammation on August 31, 2026.

25 Sep 2026

New tool to mutate phages boosts the fight against superbugs

A new tool to mutate bacteriophages – viruses that infect bacteria – provides a "big leap" forward in both our understanding of how they function, and our ability to harness their full potential.

25 Sep 2026

Researchers find secret protein that drives cancer cell division

A previously unknown protein, hidden in RNA thought not to encode proteins, helps cells divide correctly. The RNA molecule that encodes the protein also has a function of its own in cell division.

25 Sep 2026

Blood proteins may help monitor Alzheimer’s treatment response

Patients with early symptoms of Alzheimer's disease may be prescribed anti-amyloid therapy, which can help clear the sticky clumps of amyloid protein in the brain that characterize Alzheimer's.

25 Sep 2026

Intuitive eating may be linked to more than a healthier relationship with food

A cross-sectional study of 1,057 U.S. adults examined how intuitive eating relates to stress, sleep, physical activity, substance use, diet, self-rated health, and self-reported cardiometabolic conditions. Higher intuitive eating scores were associated with several favorable health indicators, although the study cannot establish causality or determine the direction of these relationships.

25 Sep 2026

Neuromedin U drives immune suppression in aggressive prostate cancer

A new study from The Wistar Institute has found a link between the nervous system and the rapid development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease.

24 Sep 2026

USP15 enzyme emerges as potential target for ovarian cancer treatment

Ovarian cancer is often diagnosed after it has already spread to other parts of the body, at which point the five-year survival rate is under 30 percent.

24 Sep 2026

Study identifies shared pathway driving cardiac fibrosis

Three adenosine receptor subtypes that normally send different signals were found to converge on a common pathway that activates cardiac fibroblasts, the scar-forming cells in the heart.

24 Sep 2026

Beetroot juice may make swimming feel easier without making swimmers faster

A systematic review and meta-analysis of 12 studies, with nine contributing data from 120 swimmers, found no significant improvement in swimming time-trial performance or post-exercise blood lactate with beetroot juice or dietary nitrate supplementation. Supplementation produced a small reduction in perceived exertion, but the effect varied across studies, and the certainty of evidence for swimming performance was low.

24 Sep 2026